32
售价212万美元，FDA批准“史上最贵药物”
source link: https://tech.sina.com.cn/d/f/2019-05-27/doc-ihvhiews4859558.shtml
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
来源：环球科学5月24日，FDA宣布批准了第一款用于治疗小儿脊髓性肌萎缩症（SMA）的基因疗法Zolgensma。Zolgensma由AveXis公司研发，2018年4月，诺华收购了AveXis，并获得了该基因疗法。SMA是一种罕见的遗传性
Recommend
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK